•  
  •  
  •  
  •  

2025-11-15 12:46:36

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Lenskart launches Meller sunglasses in India
  • Glenmark Pharmaceuticals Announces Q2FY26 Results
  • Calcom Vision Reports Q2 FY26 PAT at Rs 1.98 crore, up 18.9% YoY
  • Steel Exchange India Ltd enters into MoU with APEDB
  • ideaForge Technology Ltd receives order worth approx. Rs. 32 crores

Keywords Selected:  ClinicalTrials

Stock Report

  • Indian Regulatory Authority - SEC approval for conducting Phase III Clinical trials for Recombinant Human Albumin (rHA) 20%
  • Zydus and ICMR initiate a Phase 2 proof-of-concept trial of Desidustat in patients with Sickle Cell Disease
  • TCS ADD™ Connected Clinical Trials Wins the India Pharma Award 2022
  • TCS Launches Risk-Based Monitoring Solution that Transforms Clinical Operational Analytics and Enhances Study Quality
  • Sun Pharma Presents Phase 3 Data for WINLEVI® (clascoterone) cream 1% for the Topical Treatment of Acne Vulgaris at the AAD Annual Meeting

Latest Post

  • Lenskart launches Meller sunglasses in India
  • Glenmark Pharmaceuticals Announces Q2FY26 Results
  • Calcom Vision Reports Q2 FY26 PAT at Rs 1.98 crore, up 18.9% YoY
  • Steel Exchange India Ltd enters into MoU with APEDB
  • ideaForge Technology Ltd receives order worth approx. Rs. 32 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024